Sun Pharma
Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India
September 14, 2023Sales and Marketing License Agreement, Neurology, Pharmazz, Sun Pharma, Tyvalzi, sovateltide
Sun Pharma has announced that one of its wholly owned subsidiaries has entered into a license agreement with Pharmazz in …
Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge
January 18, 2019Medical Communications India, Sun Pharma, pharma
Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …
Sun Pharma’s New Jersey manufacturing overhaul puts 96 jobs at risk
November 26, 2018Manufacturing and Production, Sales and Marketing Sun Pharma, manufacturing, pharma
Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to …
Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer
May 23, 2018Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer
Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
Top Ten most popular articles on Pharmafile.com this week
March 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten
As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
Sun Pharma receives approval for first biologic drug
March 22, 2018Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical
The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …
Sun Pharma signs $55m manufacturing deal for investigational psoriasis drug
July 4, 2017Manufacturing and Production Samsung BioLogics, Sun Pharma
India’s biggest pharma firm has signed a $55 million long-term manufacturing deal with Korea’s Samsung BioLogics for Tildrakizumab, an investigational …
Sun Pharma rises again with FDA cholesterol drug approval
June 13, 2017Manufacturing and Production Sun Pharma
Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …
Egypt and India ties in pharmaceuticals encouraged
April 11, 2017Manufacturing and Production Egypt, India, Sun Pharma
India and Egypt have been tentatively trying to build economic links for the last few years, with a particular focus …
FDA lifts block on Sun Pharma facility
March 14, 2017Manufacturing and Production FDA, Sun Pharma
Sun Pharma has announced that the FDA informed it that the Import Alert in place upon its Mohali manufacturing facility …
Sun Pharma inaugurates first Egypt production facility
February 23, 2017Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma
Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …
Daiichi pulls out of India with closure of 170-strong R&D plant
January 11, 2017Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma
Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …
Blast at Sun Pharma factory kills two
January 4, 2017Medical Communications, Research and Development Sun Pharma, factory, fire
A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …
Sun Pharma to acquire Novartis’s drug for $175 million
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma
Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …
Sun Pharma’s Halol plant’s leaky roof irks FDA
December 13, 2016Manufacturing and Production FDA, Sun Pharma, inspection
The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …
